Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Macchia

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Public Health in Practice (Oxford, England)|September 12, 2022
Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly populationM A Kundro, M H Losso, A Macchia, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1A Gonzalo-Paulano, A Macchia, A Schaub-Clerigué, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Public Health in Practice (Oxford, England)|September 12, 2022
Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly populationM A Kundro, M H Losso, A Macchia, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1A Gonzalo-Paulano, A Macchia, A Schaub-Clerigué, et al.
Pageof 6